Ignite Creation Date:
2024-05-06 @ 2:20 PM
Last Modification Date:
2024-10-26 @ 1:29 PM
Study NCT ID:
NCT04285736
Status:
COMPLETED
Last Update Posted:
2020-02-26
First Post:
2020-02-24
Brief Title:
Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI
Sponsor:
Cairo University
Organization:
Cairo University
Study Overview
Official Title:
The Efficacy of Oral Ivabradine in Patients Presenting With Acute Non ST-segment Elevation Myocardial Infarction NSTEMI Interventional Randomized Parallel Study
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to evaluate the beneficial effect of heart rate reduction of oral ivabradine in patients presenting with non ST-segment elevation myocardial infarction NSTEMI during acute stage post percutaneous coronary intervention versus conventional treatment
Materials and methods A total of 100 patients admitted to the emergency department National Heart Institute Cairo Egypt were randomized into two groups as follows Group A 50 patients with NSTEMI treated with ivabradine 5mg twice daily in addition to the conventional treatment Group B 50 patients with NSTEMI treated with the conventional treatment only Demographic data detailed history clinical examination chest pain onset blood pressure heart rate HR temperature and respiratory rate electrocardiogram ECG as well as echocardiography and laboratory investigations were recorded Patients were monitored for a period of 3-5 days acute stage
Materials and methods A total of 100 patients admitted to the emergency department National Heart Institute Cairo Egypt were randomized into two groups as follows Group A 50 patients with NSTEMI treated with ivabradine 5mg twice daily in addition to the conventional treatment Group B 50 patients with NSTEMI treated with the conventional treatment only Demographic data detailed history clinical examination chest pain onset blood pressure heart rate HR temperature and respiratory rate electrocardiogram ECG as well as echocardiography and laboratory investigations were recorded Patients were monitored for a period of 3-5 days acute stage
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None